GLP-1
Treatment Review
Provider reviews / CoreAge Rx

Promotional placement #1

CoreAge Rx review: read the plan before the price

Our first promotional placement offers compounded GLP-1 treatment. The important detail is how the selected supply and purchase option fit together.

Treatment category

Compounded treatment

Published offer

Semaglutide advertised at $99/mo; tirzepatide at $149/mo

Before payment

Plan length affects the monthly equivalent. Confirm the total charge and one-time versus subscription selection.

CoreAge Rx advertises compounded semaglutide and tirzepatide after a medical evaluation. Its treatment pages list semaglutide at $99 per month and tirzepatide at $149 per month. The help center adds the detail needed to interpret those numbers: plan length affects the effective monthly cost, with one-, three-, six- and twelve-month options. We have not completed a patient checkout and do not treat the headline as a verified one-month purchase quote. [Provider offer] [Provider offer] [Provider billing terms]

The offer worth examining

The published bundle includes provider review, compounded medication and shipping. The company says dose changes do not raise the price. That can make a plan easier to budget for, but confirm the medication, supply and actual charge for the option you select. A longer plan may be divided into multiple shipments; the plan duration does not guarantee a particular vial count or shipment size. [Provider billing terms]

The purchase choice that matters

CoreAge Rx distinguishes one-time purchases from optional subscriptions. Buying several months of treatment does not itself establish that the order renews. Conversely, selecting a subscription enables future automatic billing on the chosen terms. Keep the confirmation showing what you selected.

The help center says all sales are final once a prescription is approved and sent to the pharmacy. A request to stop future renewals does not cancel or refund that existing order. If you need to stop both an order and future billing, make the two requests explicit and ask the company to confirm the result. [Provider billing terms]

What the first placement means

CoreAge Rx is the publisher's first promotional placement. We have not established that it is clinically safer, more effective or more responsive than the other services here. We have not inspected pharmacies, independently checked clinician credentials or measured customer outcomes.

The products described are compounded, not FDA-approved products. FDA recommends discussing whether an approved medicine can meet your medical needs before using a compounded alternative. Get the prescriber's rationale and dispensing pharmacy details for the actual proposed treatment. [Regulator guidance]

Before deciding, compare the explicit billing amounts at Likeness and the SuperHealthy promotional offer. Use the same medication, term and amount-due basis rather than simply comparing the smallest headline numbers.

Sources & evidence notes

Public pages checked October 5, 2026. Provider pages establish what a company advertises; they do not independently verify its performance.

  1. CoreAge Rx — official treatment pagesProvider offer
  2. CoreAge Rx — tirzepatide offerProvider offer
  3. CoreAge Rx Help Center — Pricing & PlansProvider billing terms
  4. FDA — concerns with unapproved GLP-1 drugsRegulator guidance